More importantly, functional investigations, including animal studies, showed that GBM cells with a high HSP90B1 expression level had a reduced sensitivity to radiotherapy, and the knockdown ofHSP90B1in RR GBM cells re-evoked radiation-induced ROS production and apoptosis to sensitize GBM cells to radiation therapy. This evidence concerns the gene HSP90B1 and glioblastoma.